Tumor promoters bind to C1 domains (C1A and C1B) of conventional PKC (α, βI, βII, γ) and novel PKC (δ, Σ, η, θ) isozymes, and recruit them from the cytoplasm to the cell membrane to activate the enzymes [6]. The gene discussed is PRRT2; the disease is neoplasm.